MedTrace Logo

Locally Delivered 1% Metformin Gel in Peri-implantitis

NCT03312582 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2017-10-17

No results posted yet for this study

Summary

This study evaluates the efficacy of 1% local metformin gel in deep periimplant pockets of type 2 diabetes mellitus patients. Half of the participants will receive 1% metformin gel with manual debridement while the other half will receive a placebo with manual debridement.

Conditions

  • Peri-Implantitis

Interventions

DRUG

1% local metformin gel

After providing manual debridement in deep peri-implant probing depths, 1% metformin gel will be applied.

PROCEDURE

Placebo

Sponsors & Collaborators

  • King Saud University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-03-15
Primary Completion
2016-08-14
Completion
2017-07-24

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03312582 on ClinicalTrials.gov